drugset / Trial / NCT01157936

Hyperuricemia on Hypertension and Metabolic Syndrome

NCT01157936

RandomizedCrossoverQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the influence of hyperuricemia treatment compared with placebo on participants with high risk of hypertension and metabolic syndrome.

Timeline

Start
2010-07
Primary completion
2011-02
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule

Indications